AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Purple Biotech Ltd.

Regulatory Filings Apr 15, 2019

7004_rns_2019-04-15_4e79cf8b-1481-4656-b3bb-58c22f9816ce.htm

Regulatory Filings

Open in Viewer

Opens in native device viewer

_________ false

����� ����� ��"� 2 380
KITOV PHARMA LTD
Corporation no: 520031238 10994
- - -
Israel Securities Authority Tel Aviv Stock Exchange C002 ( Public ) Reported via MAGNA: 15/04/2019
www.isa.gov.il www.tase.co.il Reference: 2019-02-036979 Time of broadcast: 13:50 13:49:01

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

Please note that in the case of delayed publication of report, no changes will be allowed after the form is submitted.

Delay the publication of a report 15/04/2019 14:01

1. The delay of the report can be done up to 72 hours maximum from the date of filling out the form.2. Attention that in accordance with the provisions of the law, the reporting date must be simultaneous with the report in the foreign exchange.

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onUNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of April 2019 Commission File Number: 001-37643 KITOV PHARMA LTD. Investors Call Presentation - April 2019

f6k041519_kitovpharmaltdEDGAR1_Bannerless_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NASDAQ CM Date of revision of form structure: 19/02/2019
Address: Menachem Begin St, Azrieli Towers Round Tower 132 , Tel Aviv 6701101   , Israel Tel: 03-9333121 , Fax: 03-5097196
E-mail address: [email protected]   Company site: www.kitovpharma.com
Previous names of reporting entity: KITOV PHARMACEUTICALS HOLDINGS LTD, MAINROM LINE LOGISTICS LTD, ORLINE DEVELOPMENT AND INVESTMENT LTD, KADURY & HAI (MOLET) ASSETS & INVESTMENTS LTD,
Name of the Signatory: BEN-TZVI ABRAHAM SHLOMO Position of Signatory in the reporting corporation: Chief Legal Officer & Secretary Name of Employer Company:
Address: Menachem Begin St, Azrieli Towers Round Tower 132 , Tel Aviv 6701101 Telephone: 03-9333121 Facsimile: 03-5097196 E-mail: [email protected] 1
Israel

Talk to a Data Expert

Have a question? We'll get back to you promptly.